PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy. - Wikidata - awgldk - TriplyDB

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.

http://www.wikidata.org/entity/Q43089446

about

The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate Cancer Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS)Gleason 6 Prostate Cancer: Translating Biology into Population Health.Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.PTEN loss is associated with follicular variant of Middle Eastern papillary thyroid carcinoma Gleason Score 7 Prostate Cancers Emerge through Branched Evolution of Clonal Gleason Pattern 3 and 4.A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.Should Gleason 6 be labeled as cancer?Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.Biomarkers for prostate cancer: present challenges and future opportunities.Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.Recent advances in prostate cancer pathology: Gleason grading and beyond.Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH.Somatic molecular subtyping of prostate tumors from HOXB13 G84E carriers.The molecular underpinnings of prostate cancer: impacts on management and pathology practice.Clinical and molecular rationale to retain the cancer descriptor for Gleason score 6 disease.PRECISION MANAGEMENT OF LOCALIZED PROSTATE CANCER.Genomic tests to guide prostate cancer management following diagnosis.Low serum testosterone predicts upgrading and upstaging of prostate cancer after radical prostatectomy.A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort.Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene PTEN in prostate cancer cells.Mucinous and secondary tumors of the prostate.Investigating the role of the IGF axis as a predictor of biochemical recurrence in prostate cancer patients post-surgery.Emerging biomarkers in the diagnosis of prostate cancer.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the Literature Molecular correlates of intermediate- and high-risk localized prostate cancer

P2860

Q26738703-E6305828-FE41-47B8-B5CE-07A90BFA0CF0 Q26752510-059F7566-DD0C-4683-8AC5-4D2F1D74B4E4 Q31051724-3B8DE467-E110-4532-889D-1C8D649A7B2C Q33838513-83C8BC0B-BDC0-45FD-9549-C1510682397C Q34470640-1B822FEE-BFF5-46A3-B545-9CD767BF5C6F Q35854235-3C0582E1-1E25-4392-81E8-F1A10C43E7A4 Q36086862-3080CAE5-E4B0-4078-9503-7E4618B8E621 Q36259221-E911A7BB-D260-4A59-A0B2-EF71A37617EA Q36887707-F0C5BD37-F0E0-4E98-99A9-ED5C6FE7DEC3 Q36931932-1012FFD5-9404-4A55-9746-484308391A27 Q37029385-7A03EE46-202B-407B-BF5F-723649E7A67F Q37474443-75464BCA-BC63-4433-8710-30E7AD915E87 Q38540198-FCCD1DB1-25DA-4E08-A700-B192CC6E52DC Q38779933-CEE3FA9D-9695-44D3-98E7-1C44CA6FD228 Q38833458-F6F96A91-612A-4F13-8F19-423F2E49B752 Q38967389-C6EDF6BF-D4EF-4684-94BC-7AB39185158C Q38983790-64762DFD-3528-4ACF-AA74-8EA3C608A1AE Q39023426-606B51E5-6400-4633-A7C5-9A7AC7D7DDA9 Q39108592-A335E9CB-B3E3-43DB-8FE6-6B796A219012 Q39170943-F576E394-2EEE-44FA-92A6-F855E82BF70A Q40144303-763D2FDC-9507-4E8F-9416-200192293061 Q40978920-E871FAD0-CC92-41F4-80E2-E9A6B0D1F6F1 Q41912121-73FFE2CD-508F-4F59-B45D-D398F5D02B9A Q42371556-C7FDE467-A3EC-463E-B45E-A443B90EFAFE Q43104641-AFAA1757-A707-4429-8703-E85C30BBBD2A Q43269413-AF96A3D5-E4F6-443F-91B6-46BF6DBED15B Q46000712-E775D643-C8C7-4FBB-9E6F-FAAFAA23E898 Q46007270-35C9C7E5-B420-474B-94AA-CEBC1300B912 Q47102112-65AF76F6-64EC-4644-9F03-7A38930154F3 Q47664729-4A1C4C08-66C0-495D-8C82-2C226DFC8590 Q47758797-6EB35607-B067-418C-8DE9-8524EBC23151 Q54964875-E99CA7D9-4D77-4DE7-AF31-702671383D17 Q57073785-75E4ABEA-FD0E-4876-966A-DBB534192892 Q57109051-0C6D8678-D011-442D-8489-4F87FBEAC1D8

P2860

PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.

http://www.wikidata.org/entity/Q43089446

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@en

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@nl

type

label

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@en

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@nl

prefLabel

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@en

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@nl

P1433

Q43089446-C5DE2459-731A-4A8E-8561-81456071A02C

P1476

Q43089446-91C8895C-361F-4FB3-8DA9-F5B08549842C

P2093

Q43089446-1FEB3FB5-1513-4D74-B9DB-0326426328B1

Q43089446-58DC28F8-AC6A-41D3-BAB3-73ECCA1EADD2

Q43089446-615034CF-FCB5-45E3-B5D0-28472D2674A0

Q43089446-76CA6562-CE40-4CC7-A3E1-37BE39D3F1B9

Q43089446-AB71D409-E81B-4B8A-95A3-4DE0A39E32DC

Q43089446-B536D284-FFF0-4031-97FC-E2C1451679B8

Q43089446-BD79BA4C-EB63-41C0-9EA3-19F4E097D7C7

Q43089446-BEA02750-0FCC-4D54-BEA2-42842F9099AB

Q43089446-E042AA9D-CD51-4281-936B-D772AAAB28D3

Q43089446-EED95EA5-8D27-43A3-B590-DDE4E17A5D1B

P2860

Q43089446-08E0499B-EA9A-41CD-8230-21AE8AB55AFC

Q43089446-0BCD42F0-B2AA-47B8-91B5-85AD24FD2F68

Q43089446-1AF0A20F-93D1-4220-B2BC-28AF83DDF291

Q43089446-20F88122-308D-4995-9D76-E9927F05BDE9

Q43089446-31824939-3D7B-45E4-8B11-337D3501E037

Q43089446-32D71445-29D1-4762-BF46-AB15037D1158

Q43089446-33FD2B11-23DD-4A15-AD37-71924AF6C142

Q43089446-468BA768-56CA-4D3A-9425-909C3F0D254B

Q43089446-5C3DE3CA-9E33-4E41-8101-2D5A0347AE17

Q43089446-629BE7D2-A43F-4857-91C5-AEE6CE6FB443

P2888

Q43089446-524533A0-03C3-4D3D-B007-D6356781FECF

P304

Q43089446-3074D846-3DD4-4290-8615-76923E8B2200

P31

Q43089446-F458E188-51B2-4566-81E2-AE3D79179986

P356

Q43089446-257739E9-8A6E-481F-84F2-8D5C4200BB70

P433

Q43089446-07E23097-E0E6-4C02-AA52-71C8962C3176

P478

Q43089446-0417A373-54F3-4149-AFCF-552C3090711D

P50

Q43089446-AAB28690-EFA6-4ED4-B025-7AF643C7EEF7

P577

Q43089446-9938A8CB-510D-4111-9694-8A6F02705969

P5875

Q43089446-7058318B-A7A8-4675-85DB-E22DD44E6B4C

P6179

Q43089446-AC3A8057-FDD4-42FB-B30E-A214968476B2

P698

Q43089446-305B265E-9DAC-4052-B5CC-903F168D832A

P932

Q43089446-23FFD961-6E87-43AB-8927-6CE891B53F33

P356

MODPATHOL.2014.85

P1433

Modern Pathology

P1476

PTEN loss is associated with u ...... opsy to radical prostatectomy.

@en

P2093

Angelo M De Marzo

http://www.w3.org/2001/XMLSchema#string

David M Berman

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Platz

http://www.w3.org/2001/XMLSchema#string

Elizabeth Humphreys

http://www.w3.org/2001/XMLSchema#string

Filipe Lf Carvalho

http://www.w3.org/2001/XMLSchema#string

Helen Fedor

http://www.w3.org/2001/XMLSchema#string

Jennifer Good

http://www.w3.org/2001/XMLSchema#string

Jeremy A Squire

http://www.w3.org/2001/XMLSchema#string

Jessica L Hicks

http://www.w3.org/2001/XMLSchema#string

Misop Han

http://www.w3.org/2001/XMLSchema#string

P2860

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

The genomic complexity of primary human prostate cancer

FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.

The mutational landscape of lethal castration-resistant prostate cancer

Natural history of progression after PSA elevation following radical prostatectomy.

Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men

Clonal progression of prostate cancers from Gleason grade 3 to grade 4.

Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer

P2888

modpathol.2014.85

P304

128-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MODPATHOL.2014.85

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263746870

http://www.w3.org/2001/XMLSchema#string

P6179

1005769154

http://www.w3.org/2001/XMLSchema#string

P698

24993522

http://www.w3.org/2001/XMLSchema#string

P932

4282985

http://www.w3.org/2001/XMLSchema#string